A new validated liquid chromatographic method for the determination of loratadine and its impurities

Scientia Pharmaceutica

Volumn 79, Issue 2, 2011, Pages 277-291

  Ramulu, Gajjela ^a,b   Ravindra Kumar, Yalavarthi ^a   Vyas, Krishnamurthy ^a   Suryanarayana, Mulukutla V ^a   Mukkanti, Khagga ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Loratadine; Related impurities; RP LC; Stability Indicating; Validation

Indexed keywords

8 CHLORO 11 (1 METHYLPIPERIDIN 4 YLIDENE) 6,11 DIHYDRO 5H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDINE; DESLORATADINE; ETHYL 4 (5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE)PIPERIDINE 1 CARBOXYLATE; ETHYL 4 (8 BROMO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE)PIPERIDINE 1 CARBOXYLATE; ETHYL 4 (8 CHLORO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE)PIPERIDINE 1 CARBOXYLATE; LORATADINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IMPURITY; DRUG STABILITY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; REVERSED PHASE LIQUID CHROMATOGRAPHY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 79959316849     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1012-13     Document Type: Article

References (9)

1. Claritin Rx list. The Internet Drug Index. http://www.rxlist.com/Claritin-drug.htm
2. Qi M, Wang P, Geng Y. Determination of desloratadine in drug substance and pharmaceutical preparations by liquid chromatography. J Pharm Biomed Anal. 2005; 38: 355-359. doi:10.1016/j.jpba.2005.01.003.
3. Albu M, David V, Tachea F, Medvedovicia A. HPLC/DAD Assay of Related Impurity Ethyl-4-oxopiperidine-1-carboxylate in Loratadine Through Derivatization with 2,4-Dinitrophenylhydrazine. J Liq Chromatogr Relat Technol. 2009; 32: 2569-2583. doi:10.1080/10826070903249757.
4. Reddy KV, Babu JM, Kumar YR, Reddy SV, Kumar MK, Eswaraiah S, Reddy KR, Reddy MS, Bhaskar BV, Dubey PK, Vyas K. Impurity profile study of loratadine. J Pharm Biomed Anal. 2003; 32: 29-39. doi:10.1016/S0731-7085(03)00056-6.
5. Lu J, Wei YC, Markovich RJ, Rustum AM. Development and validation of a novel stability-indicating reversed-phase high-performance liquid chromatography method for assay of loratadine and determination of its related compounds. J AOAC Int. 2010; 93: 891-903. PMid:20629392.
6. Zheng J, Rustum AM. Rapid separation of desloratadine and related compounds in solid pharmaceutical formulation using gradient ion-pair chromatography. J Pharm Biomed Anal. 2010; 51: 146-152. doi:10.1016/j.jpba.2009.08.024.
7. El-Sherbiny DT, El-Enany N, Belal FF, Hansen SH. Simultaneous determination of loratadine and desloratadine in pharmaceutical preparations using liquid chromatography with a microemulsion as eluent. J Pharm Biomed Anal. 2007; 43: 1236-1242. doi:10.1016/j.jpba.2006.10.027.
8. International conference on Harmonization. Validation of Analytical Procedure.Text and Methodology Q2 (R1). ICH, IFPMA, Geneva, 2005.
9. International conference on Harmonization. Stability testing of New drug Substances and Product (Q1AR). ICH, IFPMA, Geneva, 2002.